Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei

Journal of Endocrinology

Volumn 176, Issue 1, 2003, Pages 103-110

  Pyle, M E ^a   Korbonits, M ^a   Gueorguiev, M ^a   Jordan, S ^a   Kola, B ^a   Morris, D G ^a   Meinhardt, A ^b   Powell, M P ^c   Claret, F X ^d   Zhang, Q ^d   Metz, C ^e   Bucala, R ^f   Grossman, A B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e PICOWER INST FOR MEDICAL RESEARCH   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROLACTIN; PROTEIN C JUN; PROTEIN P27;

ADULT; AGED; CARCINOGENESIS; CELL CYCLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0037258783     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1760103     Document Type: Review

References (24)

1. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A & Bucala R 1993 MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 756-759.
2. Bernhagen J, Calandra T & Bucala R 1998 Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. Journal of Molecular Medicine 76 151-161.
3. Bloom BR & Bennett B 1966 Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 80-82.
4. Calandra T, Bernhagen J, Mitchell RA & Bucala R 1994 The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Journal of Experimental Medicine 179 1895-1902.
5. Calandra T, Spiegel LA, Metz CN & Bucala R 1998 Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. PNAS 95 11383-11388.
6. Claret FX, Hibi M, Dhut S, Toda T & Karin M 1996 A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383 453-457.
7. David JR 1966 Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. PNAS 56 72-77.
8. Edwards MC & Gibbs RA 1994 Multiplex PCR: advantages, development and applications. PCR Methods and Applications 3 S65-S75.
9. Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky M, Bucala R & Grossman AB 2002 Response of serum macrophage migration inhibitory factor (MIF) levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 87 1834-1840.
10. Jacobs RA, Dahia PLM, Satta M, Chew SL & Grossman ABi 1997 Induction of nitric oxide synthase and interleukin-1b, but not heme oxygenase, messenger RNA in rat brain following peripheral administration of endotoxin. Molecular Brain Research 49 238-246.
11. Kleemann R, Hausser A, Geiger G, Mischke R, Burger Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H & Bernhagen J 2000 Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408 211-216.
12. Korbonits M, Jacobs RA, Aylwin SJB, Burrin JM, Dahia PLM, Monson JP, Trainer PJ, Chew SL, Besser GM & Grossman AB 1998 Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 83 3624-3630.
13. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K & Grossman AB 2001a The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumours. Journal of Clinical Endocrinology and Metabolism 86 881-887.
14. Korbonits M, Chitnis MM, Gueorguiev M, Norman D, Rosenfelder N, Suliman M, Jones TH, Noonan K, Fabbri A, Besser GM, Burrin JM & Grossman AB 2001b The release of leptin and its effect on hormone release from human pituitary adenomas. Clinical Endocrinology 54 781-789.
15. Kip1 protein and Jab1 (Jun activation domain-binding protein 1) in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism 87 2635-2643.
16. Kovacs K, Rotondo F, Stefaneanu L, Fereidooni F, Horvath E, Lloyd RV & Scheithauer BW 2001 Glucocorticoid receptor expression in nontumorous human pituitaries and pituitary adenomas. Endocrine Pathology 11 267-275.
17. Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. Journal a Clinical Endocrinology and Metabolism 84 3823-3830.
18. Meyer-Siegler K & Hudson PB 1996 Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 48 448-452.
19. Mitchell RA, Metz CN, Peng T & Bucala R 1999 Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. Journal of Biological Chemistry 274 18100-18106.
20. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K & Bucala R 1995 Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Molecular Medicine 1 781-788.
21. Rogatsky I, Trowbridge JM & Garabedian MJ 1997 Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Molecular and Cellular Biology 17 3181-3193.
22. Roger T, David J, Glauser MP & Calandra T 2001 MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414 920-924.
23. Tampanaru-Sarmesiu A, Stefaneanu L, Thapar K, Kovacs K, Donnelly T, Metz CN & Bucala R 1997 Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas. Archive of Patholology and Laboratory Medicine 121 404-410.
24. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC & David JR 1989 Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. PNAS 86 7522-7526.